Watson Rebecca’s Bristol-Myers Squibb BMY Stock Holding History

Watson Rebecca’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-1,461	Closed	-$86K	–	115
2020 Q2	$86K	Buy	+1,461	New	+$87.4K	0.05%	122

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

Watson Rebecca's BMY Position: Q3 2020 in Review

Watson Rebecca sold out of Bristol-Myers Squibb (BMY) in Q3 2020, closing a stake of 1,461 shares — an estimated $86K sold.

Watson Rebecca first reported a position in BMY in Q2 2020 and held it in 1 quarter. The position peaked at $86K in Q2 2020. 2,214 funds tracked by Wall St. Rank hold BMY as of Q3 2020.

Watson Rebecca reported no remaining Bristol-Myers Squibb position as of Q3 2020 after selling out during the quarter.
Watson Rebecca sold 1,461 Bristol-Myers Squibb shares in Q3 2020, an estimated $86K.
Watson Rebecca first reported a position in Bristol-Myers Squibb in Q2 2020 and held it in 1 quarter.
Watson Rebecca's Bristol-Myers Squibb position peaked at $86K in Q2 2020.
2,214 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2020.

Based on Watson Rebecca's 13F filing for Q3 2020, filed 22 Oct 2020.